Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis todayheadline
Explore the exciting world of Axsome Therapeutics (NASDAQ: AXSM) with our expert analysts in this Motley Fool Scoreboard episode. Check ...
Read moreDetailsTag: Therapeutics
Why Viking Therapeutics Stock Popped Again Today todayheadline
Cantor Fitzgerald thinks the GLP-1 diet drug VK2735 will be a "multi-blockbuster" for Viking stock. Shares of Viking Therapeutics (VKTX ...
Read moreDetailsWhy Viking Therapeutics Stock Popped Today todayheadline
2025 is the year we learn whether Viking Therapeutics stock will be a winner. Viking Therapeutics (VKTX -1.08%) stock inched ...
Read moreDetails
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide todayheadline
Eli Lilly has a plan to dominate the GLP-1 weight loss drug market -- and it's succeeding. It's Thursday morning, ...
Read moreDetailsWhy Verve Therapeutics Is Skyrocketing Today todayheadline
Verve Therapeutics (VERV 24.52%) stock is seeing explosive gains Tuesday. The biotech company's share price was up 24.5% as of ...
Read moreDetails
Sarepta Therapeutics (SRPT) Q4 2024 Earnings Call Transcript todayheadline
SRPT earnings call for the period ending December 31, 2024. Image source: The Motley Fool. Sarepta Therapeutics (SRPT -0.08%)Q4 2024 ...
Read moreDetailsWhy Summit Therapeutics Stock Rocketed 6% Higher on Friday todayheadline
Summit Therapeutics (SMMT 5.82%) stock got a real shot in the arm Friday with the initiation of coverage by a ...
Read moreDetailsHere’s Yet Another Reason to Buy Viking Therapeutics Stock Like There’s No Tomorrow todayheadline
Viking Therapeutics (VKTX 2.04%) is a hot biotech stock thanks to the company's record of reporting good data from its ...
Read moreDetails
